Atlas Trials

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Clinical trial NCT00534261 · COMPLETED

Trial details

NCT number
NCT00534261
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
1999-11-01
Enrollment
284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.